Gastrointestinal Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 AZRX Fell Below 20 DMA Bearish
2021-02-25 CRHM Narrow Range Bar Range Contraction
2021-02-25 IRWD Lower Bollinger Band Walk Weakness
2021-02-25 KIN 50 DMA Resistance Bearish
2021-02-25 QDEL Lower Bollinger Band Walk Weakness
2021-02-25 SNGX Fell Below 20 DMA Bearish
2021-02-25 SNGX Fell Below 50 DMA Bearish
2021-02-25 SNGX New Downtrend Bearish
2021-02-25 VIVO 50 DMA Resistance Bearish

Recent News for Gastrointestinal Disease Stocks

Date Stock Title
Feb 26 ALBO Albireo Spotlights Global Patient Communities on Rare Disease Day
Feb 26 ALBO Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript
Feb 26 CRHM INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER
Feb 26 ALBO Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript
Feb 25 ALBO Albireo Pharma, Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 25 KIN Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US
Feb 25 KIN Kindred submits efficacy data to support KIND-030 prophylactic indication approval
Feb 25 ALBO Albireo Pharma EPS beats by $0.59, beats on revenue
Feb 25 KIN Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication
Feb 25 ALBO Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
Feb 25 KIN Is Kindred Biosciences (NASDAQ:KIN) Using Too Much Debt?
Feb 24 CRHM CRH MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CRH Medical Corporation - CRHM
Feb 24 SNGX Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter
Feb 24 AZRX AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors
Feb 23 VIVO Cannabis Stock Gainers And Losers From February 23, 2021
Feb 23 VIVO SHAREHOLDER ALERT: Meridian Bioscience, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm
Feb 23 VIVO Meridian Bioscience issues correction: It can't ship its Revogene SARS-CoV-2 test until EUA is granted
Feb 23 VIVO Meridian Bioscience corrects prior update on Revogene sars-cov-2 EUA withdrawal
Feb 23 VIVO Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
Feb 23 VIVO Meridian Bioscience Pulls Out Revogene COVID-19 Test EUA Application